EUVIMEDEUVIMED entdecken
Metaanalyse

Local and systemic effects of IDH mutations on primary glioma patients

Feng Tang iD, Dan-Wen Wang, Chen Xi, Jin-Zhou Yang, Zhen-Yuan Liu, Dong-Hu Yu, Ze-Fen Wang, Zhi-Qiang Li

Immunology · 2023

DOI: 10.1111/imm.13649 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Immunology, 2023. Verfasst von Feng Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Brain Glioma Center & Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adult gliomas are divided into isocitrate dehydrogenase (IDH) wild‐type and IDH mutant subtypes according to the new 2021 World Health Organization classification system. However, the local and systemic effects of IDH mutations on primary glioma patients are not well illustrated. Retrospective analysis, immune‐cell infiltration analysis, meta‐analysis, and immunohistochemistry assay were applied in the present study. The results from our cohort showed that IDH mutant gliomas own a lower proliferating rate compared to that in wild‐type gliomas. Patients with mutant IDH exhibited a higher frequency of seizures in both our cohort and the cohort from the meta‐analysis. Mutations in IDH result in lower levels of intra‐tumour but higher levels of circulating CD4+ and CD8+ T lymphocytes. Levels of neutrophils in both intra‐tumour and circulating blood were lower in IDH mutant gliomas. Moreover, IDH mutant glioma patients receiving radiotherapy in combination with chemotherapy exhibited better overall survival with respect to radiotherapy alone. Mutations in IDH alters the local and circulating immune microenvironment, and increases the sensitivity of tumour cell to chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGliomaAdultHumansIsocitrate DehydrogenaseRetrospective StudiesMutationTumor Microenvironment

Stichwörter der Autor:innen

IDHgliomaimmune microenvironmentlocal and systemic

Substanzen

Isocitrate Dehydrogenase

Autor:innen und Institutionen

  • Brain Glioma Center & Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
  • Department of Physiology, Wuhan University School of Basic Medical Sciences, Wuhan, Hubei, China.

ORCID-Profile: Feng Tang

Zitieren

APA

Tang, F., Wang, D. W., Xi, C., Yang, J. Z., Liu, Z. Y., Yu, D. H., Wang, Z. F., & Li, Z. Q. (2023). Local and systemic effects of IDH mutations on primary glioma patients. Immunology. https://doi.org/10.1111/imm.13649

Vancouver

Tang F, Wang DW, Xi C, Yang JZ, Liu ZY, Yu DH, et al. Local and systemic effects of IDH mutations on primary glioma patients. Immunology. 2023. doi:10.1111/imm.13649

BibTeX
@article{Tang2023,
  author = {Tang, Feng and Wang, Dan-Wen and Xi, Chen and Yang, Jin-Zhou and Liu, Zhen-Yuan and Yu, Dong-Hu and Wang, Ze-Fen and Li, Zhi-Qiang},
  title = {Local and systemic effects of IDH mutations on primary glioma patients},
  journal = {Immunology},
  year = {2023},
  doi = {10.1111/imm.13649}
}
Kostenlos starten →